Nicotinamide Riboside fights back Alzheimer’s disease in mouse model
Just before 2017 comes to an end the Ecole Polytechnique Fédérale de Lausanne published in Nature magazine the results of
Read moreJust before 2017 comes to an end the Ecole Polytechnique Fédérale de Lausanne published in Nature magazine the results of
Read moreA remarkable study was published about the treatment of a 77-year-old Caucasian man with severe dementia and behavioral disturbance. The
Read moreAlzheimer’s disease (AD) is the most common neurodegenerative disorder that affects the elderly. AD is characterized by a progressive impairment
Read moreAlzheimer’s disease (AD) is most prominently characterized by the accumulation of amyloid plaques and neurofibrillary tangles. The beta-amyloid (Aβ) oligomers
Read moreGood news for chocolate lovers as positive results of another study into the health benefits of chocolate were released. Building
Read moreAlzheimer’s disease (AD) is a devastating and progressive neurodegenerative disease and is attributed to a number of factors such as
Read moreAlzheimer’s disease (AD) is the most common form of dementia, showing an increasing rate of morbidity in the elderly population
Read moreDepression is now widely regarded as a common disabling disorder that affects negatively the social functioning of many all over
Read moreFisetin became the focus of investigations when researchers discovered a positive correlation between strawberry consumption and mental functioning. Since research
Read moreResearchers at Washington University Medical School were published a report in which Nicotinamide Riboside showed the ability to rescue neurons
Read more